Related Experiment Videos
Transfer of genetically engineered cells to the glomerulus.
1Glomerular Bioengineering Unit, Department of Medicine, University College London Medical School, The Rayne Institute, London, UK. m.kitamura@medicine.ucl.ac.uk
Experimental Nephrology
|June 3, 1999
Summary
Engineered cells can be transferred to the glomerulus to create chimeric glomeruli. This method aids in studying gene function and developing therapies for kidney diseases.
Area of Science:
- Nephrology
- Cell Biology
- Genetics
Background:
- Cultured cells injected into rat renal circulation are entrapped in the glomerulus.
- This allows for the creation of chimeric glomeruli populated with genetically engineered cells.
Purpose of the Study:
- To explore the use of adoptive cell transfer to the glomerulus for kidney research.
- To investigate the potential of engineered cells for identifying gene product function and treating glomerular diseases.
- To elucidate the role of leukocytes in glomerular pathophysiology and their interactions with resident cells.
Main Methods:
- In vitro engineering of glomerular cells and leukocytes.
- Intra-renal arterial injection of engineered cells in rats.
- Generation of chimeric glomeruli with genetically modified cells.
- Analysis of gene product expression and cellular interactions within the glomerulus.
Main Results:
- Glomeruli can be engineered to produce recombinant gene products using transferred cells.
- Engineered leukocytes can be used to study the impact of specific gene functions on glomerular pathophysiology.
- The model allows investigation of resident cell modulation of infiltrating cell activity.
Conclusions:
- Adoptive transfer of engineered cells to the glomerulus is a valuable tool for kidney research.
- This approach facilitates the study of local gene function and offers therapeutic potential for glomerular diseases.
- Understanding leukocyte-glomerular cell interactions is crucial for both normal kidney function and disease pathogenesis.